Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/1998
08/18/1998CA2085008C Calcium citrate malate composition
08/18/1998CA2078939C Stable salts of 5,10-methylenetetrahydrofolic acid
08/18/1998CA2036876C Derivatives having a naphthalenic structure; process for preparing the same and pharmaceutical compositions containing them
08/18/1998CA1340006C Acylated cyanamide composition
08/18/1998CA1340005C Pharmaceutical composition for the treatment of psoriasis
08/13/1998WO1998035061A2 Member of the tnf family useful for treatment and diagnosis of disease
08/13/1998WO1998035048A2 Engineered protein kinases which can utilize modified nucleotide triphosphate substrates
08/13/1998WO1998035031A1 Prostate specific regulatory nucleic acid sequences and transgenic non-human animals expressing prostate specific antigen
08/13/1998WO1998034959A1 Dermatan disulfate, an inhibitor of thrombin generation and complement activation
08/13/1998WO1998034958A1 O-sulfated bacterial polysaccharides
08/13/1998WO1998034947A1 ANTIGESTAGENIC STEROIDS WITH A FLUORINATED 17α-ALKYL CHAIN
08/13/1998WO1998034942A2 Dinucleotides and their use
08/13/1998WO1998034936A1 Carbapenem compounds, use thereof, and intermediate compounds of the same
08/13/1998WO1998034935A1 Fibrinogen receptor antagonist prodrugs
08/13/1998WO1998034934A1 Amino acid ester containing azole antifungals
08/13/1998WO1998034933A1 (4-piperidinyl)-1h-2-benzopyran derivatives useful as antipsychotic agents
08/13/1998WO1998034932A1 Hiv integrase inhibitors
08/13/1998WO1998034929A1 Il-8 receptor antagonists
08/13/1998WO1998034923A1 Phenylbenzimidazole derivatives as ligands for gaba receptors
08/13/1998WO1998034922A1 Prophylactic or therapeutic agent for diabetic complication
08/13/1998WO1998034921A1 Bicyclic inhibitors of protein farnesyl transferase
08/13/1998WO1998034920A1 2-amino substituted pyridines for use in the treatment of arteriosclerosis and hyperlipoproteinaemia
08/13/1998WO1998034919A1 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines
08/13/1998WO1998034918A1 Arylsulfonyl hydroxamic acid derivatives
08/13/1998WO1998034917A2 Synthesis of acyclic nucleoside derivatives
08/13/1998WO1998034916A1 11,15-o-dialkylprostaglandin e derivatives, process for producing the same, and drugs containing the same as the active ingredient
08/13/1998WO1998034915A1 N-hydroxy-beta-sulfonyl-propionamide derivatives and their use as inhibitors of matrix metalloproteinases
08/13/1998WO1998034910A1 Glycerolipidic compounds used for the transfer of an active substance into a target cell
08/13/1998WO1998034909A1 Bi-aromatic compounds, compositions containing them and uses
08/13/1998WO1998034907A1 Compounds consisting in particular of effectors of the central nervous system receptors sensitive to excitatory amino acids, preparation and biological applications
08/13/1998WO1998034895A1 5-hydroxyalkyl substituted phenyls and their use in medicaments for the treatment of arteriosclerosis and hyperlipoproteinaemia
08/13/1998WO1998034647A1 Arginine silicate inositol complex and use thereof
08/13/1998WO1998034643A1 Pharmaceutically active agents that impede the formation of amyloid by impeding the genesis or growth of dms
08/13/1998WO1998034632A1 Compounds and compositions for delivering active agents
08/13/1998WO1998034630A1 Use of gastrointestinal lipase inhibitors
08/13/1998WO1998034629A1 Process for preparing synthetic soil-extract materials and medicaments based thereon
08/13/1998WO1998034628A1 Composition for the treatment of haemorrhoids and other anorectal inflammations
08/13/1998WO1998034625A1 Substance and method for reduction of lipids and cholesterol
08/13/1998WO1998034622A1 Methods for the administration of amifostine
08/13/1998WO1998034621A1 Composition and method for supplementing testosterone in women with symptoms of testosterone deficiency
08/13/1998WO1998034620A1 Methods for in vivo reduction of cyanide levels and compositions useful therefor
08/13/1998WO1998034619A1 Method for the treatment of atherosclerosis and vascular injury by prevention of vascular smooth muscle cell proliferation
08/13/1998WO1998034618A1 Composition for use as a fungistat and for the treatment of fungal infections
08/13/1998WO1998034617A1 Treatment and prevention of adhesions
08/13/1998WO1998034616A1 Treatment of skin disorders
08/13/1998WO1998034615A1 Pharmaceutical composition for treatment of synaptic dysfunction comprising an oxime
08/13/1998WO1998034614A1 Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine
08/13/1998WO1998034613A1 Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization and for treating malignancies
08/13/1998WO1998034612A1 Pharmaceutical compositions containing ibuprofen and domperidone for the treatment of migraine
08/13/1998WO1998034611A1 Methods and compositions for treating allergic asthma and other disorders using descarboethoxyloratadine
08/13/1998WO1998034610A1 Composition for improving hair regrowth and method of use
08/13/1998WO1998034609A1 Cardioprotective products
08/13/1998WO1998034608A1 Methods for treatment or prophylaxis of menopausal symptoms
08/13/1998WO1998034607A1 Tetrahydrolipstatin containing compositions
08/13/1998WO1998034606A1 Melanins with improved ability to inhibit hiv replication
08/13/1998WO1998034605A1 Method of administering edta complexes
08/13/1998WO1998034604A1 ANTI-PARASITIC ACTION OF N,N-DIETHYL-m-TOLUAMIDE (DEET) AND FORMULATIONS THAT PROLONG ITS ACTIVITY IN THE SKIN
08/13/1998WO1998034603A1 Use of betulin and analogs thereof to treat herpesvirus infection
08/13/1998WO1998034602A2 Mediation of cytokines by melanin
08/13/1998WO1998034601A2 Method for inhibiting intracellular viral replication
08/13/1998WO1998034600A1 Extendible transdermal therapeutic system
08/13/1998WO1998034599A1 Microgranules containing cisplatin
08/13/1998WO1998034595A1 Medical aerosol formulations
08/13/1998WO1998034593A1 Method of treating dry eye disease with purinergic receptor agonists
08/13/1998WO1998034592A1 Topical drug preparations
08/13/1998WO1998034584A2 Compounds and method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids
08/13/1998WO1998034583A2 Enhanced anti-angiogenic activity of permanently charged derivatives of steroid hormones
08/13/1998WO1998030709A3 Non-immunogenic prodrugs and selectable markers for use in gene therapy
08/13/1998WO1998028299A3 Imidazopyridazines
08/13/1998WO1998027959A3 New aqueous medicament preparations for the production of propellent gas-free aerosols
08/13/1998WO1998025887A3 Formulations and polymorphic forms of desferrioxamine and the preparation thereof
08/13/1998WO1998025596A3 Use of a 6-aryl pyrimidine compound for treating multiple sclerosis
08/13/1998WO1998024432A3 Use of indolinone compounds as modulators of protein kinases
08/13/1998WO1998019512A3 Method for the preparation of citalopram
08/13/1998WO1998018917A3 RIBOFLAVIN MUTANTS AS VACCINES AGAINST $i(ACTINOBACILLUS PLEUROPNEUMONIAE)
08/13/1998WO1998018466A3 Anti-neurogenic inflammatory compounds and compositions and methods of use thereof
08/13/1998WO1998004290A3 Compositions comprising an inducing agent and an anti-viral agent for the treatment of blood, viral and cellular disorders
08/13/1998WO1997045098A3 Esters of vitamin e as products for topical application
08/13/1998DE3790166C2 Pure stereoisomers of N-cyclopropyl-methyl-nor-morphine cpds.
08/13/1998DE19706061A1 Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette Antiprogestin effective steroids with 17alpha-fluorinated alkyl chain
08/13/1998DE19705233A1 Preparation of stable, orally administered arginine solutions
08/13/1998DE19705229A1 Mittel zur hormonalen Kontrazeption Means for hormonal contraception
08/13/1998DE19705138A1 Dehnbares transdermales therapeutisches System Stretch transdermal therapeutic system
08/13/1998DE19703950A1 Use of isoniazide for treating malaria
08/13/1998CA2625727A1 Methods for the administration of amifostine
08/13/1998CA2280518A1 Hiv integrase inhibitors
08/13/1998CA2280507A1 Substance and method for reduction of lipids and cholesterol
08/13/1998CA2280273A1 Carbapenem compounds, use thereof, and intermediate compounds of the same
08/13/1998CA2280231A1 Member of the tnf family useful for treatment and diagnosis of disease
08/13/1998CA2280181A1 Enhanced anti-angiogenic activity of permanently charged derivatives of steroid hormones
08/13/1998CA2280179A1 Anti-parasitic action of n,n-diethyl-m-toluamide (deet) and formulations that prolong its activity in the skin
08/13/1998CA2280178A1 Melanins with improved ability to inhibit hiv replication
08/13/1998CA2280140A1 Methods and compositions for treating allergic asthma and other disorders using descarboethoxyloratadine
08/13/1998CA2280051A1 Prostate specific regulatory nucleic acid sequences and transgenic non-human animals expressing prostate specific antigen
08/13/1998CA2280048A1 Il-8 receptor antagonists
08/13/1998CA2280033A1 Composition and method for supplementing testosterone in women with symptoms of testosterone deficiency
08/13/1998CA2279994A1 Extendible transdermal therapeutic system
08/13/1998CA2279982A1 Topical drug preparations
08/13/1998CA2279951A1 Compounds and method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids
08/13/1998CA2279946A1 Mediation of cytokines by melanin
1 ... 6620 6621 6622 6623 6624 6625 6626 6627 6628 6629 6630 6631 6632 6633 6634 6635 6636 6637 6638 6639 6640 ... 7860